Medical Care

Global Poliomyelitis Therapeutics Market Insights, Forecast to 2030

Poliomyelitis Therapeutics is the treatment of polimyelitis, which is a crippling and potentially deadly infectious disease.
Market Analysis and Insights: Global Poliomyelitis Therapeutics Market
The global Poliomyelitis Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Poliomyelitis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Poliomyelitis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Poliomyelitis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Poliomyelitis Therapeutics include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Poliomyelitis Therapeutics is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Poliomyelitis Therapeutics industry development. In 2023, global % revenue of Poliomyelitis Therapeutics went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Poliomyelitis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Poliomyelitis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Poliomyelitis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Poliomyelitis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Poliomyelitis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Poliomyelitis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Merck
CSL
Astellas Pharma
Emergent BioSolutions
Johnson & Johnson
Pfizer
MedImmune
Segment by Type
Medicine
Surgery
Service
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Poliomyelitis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Poliomyelitis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poliomyelitis Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Poliomyelitis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Service
1.2.5 Other
1.3 Market by Application
1.3.1 Global Poliomyelitis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Poliomyelitis Therapeutics Market Perspective (2019-2030)
2.2 Global Poliomyelitis Therapeutics Growth Trends by Region
2.2.1 Poliomyelitis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Poliomyelitis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Poliomyelitis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Poliomyelitis Therapeutics Market Dynamics
2.3.1 Poliomyelitis Therapeutics Industry Trends
2.3.2 Poliomyelitis Therapeutics Market Drivers
2.3.3 Poliomyelitis Therapeutics Market Challenges
2.3.4 Poliomyelitis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Poliomyelitis Therapeutics by Players
3.1.1 Global Poliomyelitis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Poliomyelitis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Poliomyelitis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Poliomyelitis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Poliomyelitis Therapeutics Market Concentration Ratio
3.4.1 Global Poliomyelitis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Poliomyelitis Therapeutics Revenue in 2023
3.5 Global Key Players of Poliomyelitis Therapeutics Head office and Area Served
3.6 Global Key Players of Poliomyelitis Therapeutics, Product and Application
3.7 Global Key Players of Poliomyelitis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Poliomyelitis Therapeutics Breakdown Data by Type
4.1 Global Poliomyelitis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Poliomyelitis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Poliomyelitis Therapeutics Breakdown Data by Application
5.1 Global Poliomyelitis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Poliomyelitis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Poliomyelitis Therapeutics Market Size (2019-2030)
6.2 North America Poliomyelitis Therapeutics Market Size by Type
6.2.1 North America Poliomyelitis Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Poliomyelitis Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Poliomyelitis Therapeutics Market Share by Type (2019-2030)
6.3 North America Poliomyelitis Therapeutics Market Size by Application
6.3.1 North America Poliomyelitis Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Poliomyelitis Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Poliomyelitis Therapeutics Market Share by Application (2019-2030)
6.4 North America Poliomyelitis Therapeutics Market Size by Country
6.4.1 North America Poliomyelitis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Poliomyelitis Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Poliomyelitis Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Poliomyelitis Therapeutics Market Size (2019-2030)
7.2 Europe Poliomyelitis Therapeutics Market Size by Type
7.2.1 Europe Poliomyelitis Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Poliomyelitis Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Poliomyelitis Therapeutics Market Share by Type (2019-2030)
7.3 Europe Poliomyelitis Therapeutics Market Size by Application
7.3.1 Europe Poliomyelitis Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Poliomyelitis Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Poliomyelitis Therapeutics Market Share by Application (2019-2030)
7.4 Europe Poliomyelitis Therapeutics Market Size by Country
7.4.1 Europe Poliomyelitis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Poliomyelitis Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Poliomyelitis Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Poliomyelitis Therapeutics Market Size (2019-2030)
8.2 China Poliomyelitis Therapeutics Market Size by Type
8.2.1 China Poliomyelitis Therapeutics Market Size by Type (2019-2024)
8.2.2 China Poliomyelitis Therapeutics Market Size by Type (2025-2030)
8.2.3 China Poliomyelitis Therapeutics Market Share by Type (2019-2030)
8.3 China Poliomyelitis Therapeutics Market Size by Application
8.3.1 China Poliomyelitis Therapeutics Market Size by Application (2019-2024)
8.3.2 China Poliomyelitis Therapeutics Market Size by Application (2025-2030)
8.3.3 China Poliomyelitis Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Poliomyelitis Therapeutics Market Size (2019-2030)
9.2 Asia Poliomyelitis Therapeutics Market Size by Type
9.2.1 Asia Poliomyelitis Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Poliomyelitis Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Poliomyelitis Therapeutics Market Share by Type (2019-2030)
9.3 Asia Poliomyelitis Therapeutics Market Size by Application
9.3.1 Asia Poliomyelitis Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Poliomyelitis Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Poliomyelitis Therapeutics Market Share by Application (2019-2030)
9.4 Asia Poliomyelitis Therapeutics Market Size by Region
9.4.1 Asia Poliomyelitis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Poliomyelitis Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Poliomyelitis Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Poliomyelitis Therapeutics Introduction
11.1.4 Sanofi Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Poliomyelitis Therapeutics Introduction
11.2.4 GSK Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Company Details
11.3.2 Bibcol Business Overview
11.3.3 Bibcol Poliomyelitis Therapeutics Introduction
11.3.4 Bibcol Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Company Details
11.4.2 Serum Institute Business Overview
11.4.3 Serum Institute Poliomyelitis Therapeutics Introduction
11.4.4 Serum Institute Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Details
11.5.2 Tiantan Biological Business Overview
11.5.3 Tiantan Biological Poliomyelitis Therapeutics Introduction
11.5.4 Tiantan Biological Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Company Details
11.6.2 IMBCA Business Overview
11.6.3 IMBCA Poliomyelitis Therapeutics Introduction
11.6.4 IMBCA Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec
11.7.1 Panacea Biotec Company Details
11.7.2 Panacea Biotec Business Overview
11.7.3 Panacea Biotec Poliomyelitis Therapeutics Introduction
11.7.4 Panacea Biotec Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.7.5 Panacea Biotec Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Company Details
11.8.2 Bio-Med Business Overview
11.8.3 Bio-Med Poliomyelitis Therapeutics Introduction
11.8.4 Bio-Med Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Company Details
11.9.2 Halfkin Bio-Pharmaceuticals Business Overview
11.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Therapeutics Introduction
11.9.4 Halfkin Bio-Pharmaceuticals Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Poliomyelitis Therapeutics Introduction
11.10.4 Merck Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.10.5 Merck Recent Developments
11.11 CSL
11.11.1 CSL Company Details
11.11.2 CSL Business Overview
11.11.3 CSL Poliomyelitis Therapeutics Introduction
11.11.4 CSL Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.11.5 CSL Recent Developments
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Details
11.12.2 Astellas Pharma Business Overview
11.12.3 Astellas Pharma Poliomyelitis Therapeutics Introduction
11.12.4 Astellas Pharma Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.12.5 Astellas Pharma Recent Developments
11.13 Emergent BioSolutions
11.13.1 Emergent BioSolutions Company Details
11.13.2 Emergent BioSolutions Business Overview
11.13.3 Emergent BioSolutions Poliomyelitis Therapeutics Introduction
11.13.4 Emergent BioSolutions Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.13.5 Emergent BioSolutions Recent Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Poliomyelitis Therapeutics Introduction
11.14.4 Johnson & Johnson Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.14.5 Johnson & Johnson Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Poliomyelitis Therapeutics Introduction
11.15.4 Pfizer Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.15.5 Pfizer Recent Developments
11.16 MedImmune
11.16.1 MedImmune Company Details
11.16.2 MedImmune Business Overview
11.16.3 MedImmune Poliomyelitis Therapeutics Introduction
11.16.4 MedImmune Revenue in Poliomyelitis Therapeutics Business (2019-2024)
11.16.5 MedImmune Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Poliomyelitis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Service
Table 5. Key Players of Other
Table 6. Global Poliomyelitis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Poliomyelitis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Poliomyelitis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Poliomyelitis Therapeutics Market Share by Region (2019-2024)
Table 10. Global Poliomyelitis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Poliomyelitis Therapeutics Market Share by Region (2025-2030)
Table 12. Poliomyelitis Therapeutics Market Trends
Table 13. Poliomyelitis Therapeutics Market Drivers
Table 14. Poliomyelitis Therapeutics Market Challenges
Table 15. Poliomyelitis Therapeutics Market Restraints
Table 16. Global Poliomyelitis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Poliomyelitis Therapeutics Revenue Share by Players (2019-2024)
Table 18. Global Top Poliomyelitis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Therapeutics as of 2023)
Table 19. Global Poliomyelitis Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Poliomyelitis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Poliomyelitis Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Poliomyelitis Therapeutics, Product and Application
Table 23. Global Key Players of Poliomyelitis Therapeutics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Poliomyelitis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Poliomyelitis Therapeutics Revenue Market Share by Type (2019-2024)
Table 27. Global Poliomyelitis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Poliomyelitis Therapeutics Revenue Market Share by Type (2025-2030)
Table 29. Global Poliomyelitis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Poliomyelitis Therapeutics Revenue Share by Application (2019-2024)
Table 31. Global Poliomyelitis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Poliomyelitis Therapeutics Revenue Share by Application (2025-2030)
Table 33. North America Poliomyelitis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Poliomyelitis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Poliomyelitis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Poliomyelitis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Poliomyelitis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Poliomyelitis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Poliomyelitis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Poliomyelitis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Poliomyelitis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Poliomyelitis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Poliomyelitis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Poliomyelitis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Poliomyelitis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Poliomyelitis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Poliomyelitis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Poliomyelitis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Poliomyelitis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Poliomyelitis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Poliomyelitis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Poliomyelitis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Poliomyelitis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Poliomyelitis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Poliomyelitis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Poliomyelitis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Poliomyelitis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Poliomyelitis Therapeutics Product
Table 68. Sanofi Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 69. Sanofi Recent Developments
Table 70. GSK Company Details
Table 71. GSK Business Overview
Table 72. GSK Poliomyelitis Therapeutics Product
Table 73. GSK Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 74. GSK Recent Developments
Table 75. Bibcol Company Details
Table 76. Bibcol Business Overview
Table 77. Bibcol Poliomyelitis Therapeutics Product
Table 78. Bibcol Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Company Details
Table 81. Serum Institute Business Overview
Table 82. Serum Institute Poliomyelitis Therapeutics Product
Table 83. Serum Institute Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Company Details
Table 86. Tiantan Biological Business Overview
Table 87. Tiantan Biological Poliomyelitis Therapeutics Product
Table 88. Tiantan Biological Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 89. Tiantan Biological Recent Developments
Table 90. IMBCA Company Details
Table 91. IMBCA Business Overview
Table 92. IMBCA Poliomyelitis Therapeutics Product
Table 93. IMBCA Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 94. IMBCA Recent Developments
Table 95. Panacea Biotec Company Details
Table 96. Panacea Biotec Business Overview
Table 97. Panacea Biotec Poliomyelitis Therapeutics Product
Table 98. Panacea Biotec Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 99. Panacea Biotec Recent Developments
Table 100. Bio-Med Company Details
Table 101. Bio-Med Business Overview
Table 102. Bio-Med Poliomyelitis Therapeutics Product
Table 103. Bio-Med Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 104. Bio-Med Recent Developments
Table 105. Halfkin Bio-Pharmaceuticals Company Details
Table 106. Halfkin Bio-Pharmaceuticals Business Overview
Table 107. Halfkin Bio-Pharmaceuticals Poliomyelitis Therapeutics Product
Table 108. Halfkin Bio-Pharmaceuticals Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Poliomyelitis Therapeutics Product
Table 113. Merck Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 114. Merck Recent Developments
Table 115. CSL Company Details
Table 116. CSL Business Overview
Table 117. CSL Poliomyelitis Therapeutics Product
Table 118. CSL Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 119. CSL Recent Developments
Table 120. Astellas Pharma Company Details
Table 121. Astellas Pharma Business Overview
Table 122. Astellas Pharma Poliomyelitis Therapeutics Product
Table 123. Astellas Pharma Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 124. Astellas Pharma Recent Developments
Table 125. Emergent BioSolutions Company Details
Table 126. Emergent BioSolutions Business Overview
Table 127. Emergent BioSolutions Poliomyelitis Therapeutics Product
Table 128. Emergent BioSolutions Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 129. Emergent BioSolutions Recent Developments
Table 130. Johnson & Johnson Company Details
Table 131. Johnson & Johnson Business Overview
Table 132. Johnson & Johnson Poliomyelitis Therapeutics Product
Table 133. Johnson & Johnson Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 134. Johnson & Johnson Recent Developments
Table 135. Pfizer Company Details
Table 136. Pfizer Business Overview
Table 137. Pfizer Poliomyelitis Therapeutics Product
Table 138. Pfizer Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 139. Pfizer Recent Developments
Table 140. MedImmune Company Details
Table 141. MedImmune Business Overview
Table 142. MedImmune Poliomyelitis Therapeutics Product
Table 143. MedImmune Revenue in Poliomyelitis Therapeutics Business (2019-2024) & (US$ Million)
Table 144. MedImmune Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Poliomyelitis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Poliomyelitis Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Surgery Features
Figure 5. Service Features
Figure 6. Other Features
Figure 7. Global Poliomyelitis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Poliomyelitis Therapeutics Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Poliomyelitis Therapeutics Report Years Considered
Figure 13. Global Poliomyelitis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Poliomyelitis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Poliomyelitis Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Poliomyelitis Therapeutics Market Share by Players in 2023
Figure 17. Global Top Poliomyelitis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Poliomyelitis Therapeutics Revenue in 2023
Figure 19. North America Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Poliomyelitis Therapeutics Market Share by Type (2019-2030)
Figure 21. North America Poliomyelitis Therapeutics Market Share by Application (2019-2030)
Figure 22. North America Poliomyelitis Therapeutics Market Share by Country (2019-2030)
Figure 23. United States Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Poliomyelitis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Poliomyelitis Therapeutics Market Share by Type (2019-2030)
Figure 27. Europe Poliomyelitis Therapeutics Market Share by Application (2019-2030)
Figure 28. Europe Poliomyelitis Therapeutics Market Share by Country (2019-2030)
Figure 29. Germany Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Poliomyelitis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Poliomyelitis Therapeutics Market Share by Type (2019-2030)
Figure 37. China Poliomyelitis Therapeutics Market Share by Application (2019-2030)
Figure 38. Asia Poliomyelitis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Poliomyelitis Therapeutics Market Share by Type (2019-2030)
Figure 40. Asia Poliomyelitis Therapeutics Market Share by Application (2019-2030)
Figure 41. Asia Poliomyelitis Therapeutics Market Share by Region (2019-2030)
Figure 42. Japan Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Poliomyelitis Therapeutics Market Share by Country (2019-2030)
Figure 52. Brazil Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Poliomyelitis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 59. GSK Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 60. Bibcol Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 61. Serum Institute Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 62. Tiantan Biological Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 63. IMBCA Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 64. Panacea Biotec Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 65. Bio-Med Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 66. Halfkin Bio-Pharmaceuticals Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 67. Merck Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 68. CSL Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 69. Astellas Pharma Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 70. Emergent BioSolutions Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 71. Johnson & Johnson Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 72. Pfizer Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 73. MedImmune Revenue Growth Rate in Poliomyelitis Therapeutics Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies